Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Caribou Biosciences Inc (CRBU)

Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 335,069
  • Shares Outstanding, K 90,315
  • Annual Sales, $ 34,480 K
  • Annual Income, $ -102,070 K
  • 60-Month Beta 2.47
  • Price/Sales 9.85
  • Price/Cash Flow N/A
  • Price/Book 0.92
Trade CRBU with:

Options Overview Details

View History
  • Implied Volatility 169.27% ( -1.67%)
  • Historical Volatility 34.72%
  • IV Percentile 97%
  • IV Rank 59.65%
  • IV High 247.26% on 04/22/24
  • IV Low 53.99% on 10/26/23
  • Put/Call Vol Ratio 0.36
  • Today's Volume 76
  • Volume Avg (30-Day) 115
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 4,161
  • Open Int (30-Day) 5,299

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.39
  • Number of Estimates 3
  • High Estimate -0.35
  • Low Estimate -0.44
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +15.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.69 +0.54%
on 04/26/24
5.23 -29.04%
on 03/28/24
-1.35 (-26.68%)
since 03/26/24
3-Month
3.69 +0.54%
on 04/26/24
8.33 -55.46%
on 02/28/24
-1.75 (-32.05%)
since 01/26/24
52-Week
3.44 +7.85%
on 11/01/23
8.59 -56.81%
on 07/12/23
-0.53 (-12.50%)
since 04/26/23

Most Recent Stories

More News
Why Caribou Biosciences Stock Is Crashing Today

Investors didn't like the clinical-stage biotech's Q4 update for one key reason.

CRBU : 3.71 (-1.33%)
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold

Buy this stock if you're daring, but avoid it for now if you aren't.

CRSP : 53.91 (+0.34%)
CRBU : 3.71 (-1.33%)
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare

It's less scary to take on risky investments when the market is rising.

CRBU : 3.71 (-1.33%)
VERV : 6.16 (-0.96%)
3 Biotech Stocks You Can Buy and Hold for the Next Decade

These companies are still in the early innings of their growth potential.

CPRX : 14.89 (+1.43%)
RXRX : 8.12 (+3.57%)
CRBU : 3.71 (-1.33%)
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

CRSP : 53.91 (+0.34%)
BEAM : 21.38 (-1.02%)
CRBU : 3.71 (-1.33%)
EDIT : 5.32 (+1.92%)
NTLA : 20.76 (+3.70%)
PRME : 4.43 (+2.91%)
VERV : 6.16 (-0.96%)
LLY : 733.51 (+1.19%)
REGN : 883.20 (-0.84%)
VRTX : 397.48 (-0.06%)
ARKG : 23.18 (+0.74%)
HOOD : 17.88 (+4.44%)
2 Top Growth Stocks to Buy Right Now Without Hesitation

These stocks are dirt cheap right now.

CHWY : 15.84 (+2.99%)
CRBU : 3.71 (-1.33%)
2 Exciting Biotech Stocks to Buy With Less Than $10

You can pick up these stocks for a song right now.

PFE : 25.40 (+0.55%)
CRBU : 3.71 (-1.33%)
DNA : 0.8601 (+10.60%)
A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip

Wall Street price targets suggest this stock can rocket more than 400% higher.

CRBU : 3.71 (-1.33%)
ALLO : 2.89 (+1.23%)
GILD : 65.42 (+0.23%)
2 Magnificent Growth Stocks to Buy On the Dip

It might be time to catch these falling knives.

PFE : 25.40 (+0.55%)
BEAM : 21.38 (-1.02%)
CRBU : 3.71 (-1.33%)
1 Gene Editing Stock to Buy Now, and 1 to Sell

Target markets matter. So does having the cash to get to them.

CRBU : 3.71 (-1.33%)
EDIT : 5.32 (+1.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Caribou Biosciences Inc. is a clinical-stage CRISPR genome-editing biopharmaceutical company. It involved in developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for the treatment of both hematologic malignancies and solid tumors. Caribou Biosciences Inc. is based in...

See More

Key Turning Points

3rd Resistance Point 4.05
2nd Resistance Point 3.98
1st Resistance Point 3.84
Last Price 3.71
1st Support Level 3.63
2nd Support Level 3.56
3rd Support Level 3.42

See More

52-Week High 8.59
Fibonacci 61.8% 6.62
Fibonacci 50% 6.01
Fibonacci 38.2% 5.41
Last Price 3.71
52-Week Low 3.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar